This condition is particularly concerning for individuals with diabetes, high blood pressure, or cardiovascular diseases, as they are already at a heightened risk for vascular complications
Unlike many competitors who use lower doses, our research-backed serving size delivers the concentration required to meaningfully support cellular health supplements protocols and enhance your body's natural antioxidant capacity
Over the next 48 weeks, those who stayed on semaglutide lost a further 7.9%, whereas those switched to placebo regained 6.9%
Not recommended for individuals with type 1 diabetes, patients on other GLP-1 drugs, those with a history of pancreatitis or kidney disease, and pregnant or nursing women
The reasons are biological, not cosmetic
Psychological stress and disease